- Report
- January 2022
- 100 Pages
Global
From €5306EUR$5,950USD£4,542GBP
- Report
- December 2021
- 110 Pages
Global
From €5306EUR$5,950USD£4,542GBP
- Report
- July 2021
- 104 Pages
Global
From €5306EUR$5,950USD£4,542GBP
- Report
- May 2024
- 215 Pages
United States
From €2042EUR$2,290USD£1,748GBP
- Report
- March 2023
- 130 Pages
Japan
From €2221EUR$2,490USD£1,901GBP
- Report
- March 2023
- 190 Pages
Germany
From €2221EUR$2,490USD£1,901GBP
- Report
- March 2023
- 190 Pages
Switzerland
From €2221EUR$2,490USD£1,901GBP
- Report
- February 2023
- 130 Pages
France
From €2221EUR$2,490USD£1,901GBP
- Report
- February 2023
- 130 Pages
Canada
From €2221EUR$2,490USD£1,901GBP
- Report
- February 2023
- 120 Pages
Israel
From €2221EUR$2,490USD£1,901GBP
- Report
- September 2020
- 168 Pages
Netherlands
From €1775EUR$1,990USD£1,519GBP
- Report
- April 2018
- 126 Pages
Canada
From €1685EUR$1,890USD£1,443GBP
- Report
- May 2024
- 289 Pages
Global
From €4459EUR$5,000USD£3,817GBP
- Report
- May 2024
- 226 Pages
Global
From €2898EUR$3,250USD£2,481GBP
€4325EUR$4,850USD£3,702GBP
- Report
- March 2024
Global
From €2898EUR$3,250USD£2,481GBP
€4325EUR$4,850USD£3,702GBP
- Report
- January 2024
- 150 Pages
Global
From €2898EUR$3,250USD£2,481GBP
€4325EUR$4,850USD£3,702GBP
- Report
- May 2023
- 150 Pages
Global
From €2898EUR$3,250USD£2,481GBP
€4325EUR$4,850USD£3,702GBP
- Report
- March 2023
- 150 Pages
Global
From €2898EUR$3,250USD£2,481GBP
€4325EUR$4,850USD£3,702GBP
- Report
- March 2024
- 159 Pages
Global
From €2229EUR$2,500USD£1,908GBP
- Report
- February 2024
- 158 Pages
Global
From €2229EUR$2,500USD£1,908GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more